Back

Challenging CV Risk in diabetes: ready for a new approach?

28 August 2016 (12:50 - 13:05)
Organised by:
Congress Presentation Part of: SGLT2 inhibition, diabetes and CVD: where does this fit in CV risk management? Diabetes management ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Introduction - SGLT2 inhibition, diabetes and CVD: where does this fit in CV risk management?
Doctor D. Fitchett (Toronto, CA)
Presentation thumbnail
SGLT-2 inhibitors in T2DM management: current position & future promise.
Professor S. Inzucchi (New Haven, US)
Presentation thumbnail
Heart failure & diabetes: SGLT2 inhibition, a paradigm shift?
Professor J. McMurray (Glasgow, GB)
Presentation thumbnail
Panel discussion - SGLT2 inhibition, diabetes and CVD: where does this fit in CV risk management?
Doctor D. Fitchett (Toronto, CA) Professor J. McMurray (Glasgow, GB)

Access the full session

Session thumbnail
SGLT2 inhibition, diabetes and CVD: where does this fit in CV risk management?

The Event

Event poster

ESC Congress 2016

28 August 2016 12:50 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources